A new generation of AI-native researchers is leading the way in the war on cancer. This next crop of scientists is AI-native, interdisciplinary—and comfortable challenging assumptions. 

The New York-based safety net hospital has accused former CEO Megan Ryan of impropriety that includes paying out $3.5 million to herself and 12 other executives. She denies the allegations, and claims she is a whistleblower for fraud committed by the state.

The new drug, VTB-10, previously received the FDA's orphan drug designation in 2024.

Epic confirmed on Tuesday that its long-rumored AI scribe feature is a reality. The company said it’s working with Microsoft-owned Nuance—and with clinical documentation standout Abridge—to add the feature to its platform.

About 30% of patients die within 90 days of implanting an inferior vena cava filter, yet a median of only about 6% are removed within this time span, experts write in JACR. 

Despite concerted attempts to reduce low-value imaging, the rate of individuals receiving radiographs stayed static between 2016 and 2022. 

The company operates across six countries with plans to enter the U.S., offering its flagship BMVision Kidney, helping to detect malignant lesions in the organ. 

Mahendra Amin, MD, sued Amazon and its podcast subsidiary, Wondery, after a show host accused him of performing forced hysterectomies on women detained at an ICE facility. The claims were popularized by MSNBC, which settled a similar lawsuit with the doctor earlier this year.